IP Library Granted Patent US 8,019,426
Granted Patent B2
US 8,019,426 · App. 11/879,221 · Granted Sep 13, 2011

Electrical nerve stimulation device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,019,426
App. No.
11/879,221
Granted
Sep 13, 2011
Kind
B2
Abstract

The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.

Claims (17)

1. A nerve stimulation device comprising:

at least one output channel for communicating an electrical pulse signal to a user, the at least one output channel having at least one lead wire operably connectable to the at least one output channel for communicating the electrical pulse signal;

a high voltage level power system having at least one battery source at a first voltage to provide power to the nerve stimulation device; and

a processor in operable communication with at least the high voltage level power system to calculate a second voltage lower than the first voltage and corresponding to a voltage level required to generate the electrical pulse signal, the processor further periodically monitoring a voltage capacity of the high voltage level power system and substantially maintaining the second voltage during stimulation;

wherein the second voltage is calculated from at least one treatment parameter associated with a treatment mode selected by the user.

2. The device of claim 1 , wherein the processor maintains the second voltage capacity during operation by charging a capacitor in the high voltage level power system with pulses to replace pulses used to generate the electrical pulse signal.

3. The device of claim 1 , wherein the processor calculates the second voltage based on an electrical treatment output that is based at the least one treatment parameter.

4. The device of claim 3 , wherein the at least one inputted treatment parameter includes at least one of pulse rate, pulse duration, pulse intensity, mode data, and compliance data.

5. The device of claim 1 , wherein the second voltage is less than the first voltage.

6. A nerve stimulation device comprising:

at least one output means for communicating a generated electrical pulse signal;

power means for providing power to the nerve stimulation device, the power means having a voltage source at a first voltage and a circuit means for generating a second voltage for the generated electrical pulse signal; and

control means in operable communication with at least the power means to calculate the second voltage lower than the first voltage and corresponding to a voltage level required to generate the electrical pulse signal, the control means further periodically monitoring a voltage capacity of the circuit means and substantially maintaining the second voltage during stimulation;

wherein the second voltage is calculated from at least one treatment parameter associated with a treatment mode selected by the user.

7. The device of claim 6 , wherein the processor calculates the second voltage based on an electrical treatment output that is based at the least one treatment parameter.

8. The device of claim 7 , wherein the at least one inputted treatment parameter includes at least one of pulse rate, pulse duration, pulse intensity, mode data, and compliance data.

9. The device of claim 6 , wherein the second voltage is less than the first voltage.

Assignments (17)
SECURITY INTEREST Recorded Jan 3, 2024
From: DJO, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066186/0659 →
MERGER Recorded Oct 28, 2020
From: ENCORE MEDICAL ASSET CORPORATION
To: DJO, LLC
Reel/Frame 054201/0368 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS THIRD LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048608/0932 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 050129/0262 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: MACQUARIE US TRADING LLC AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048655/0067 →
RELEASE OF SECURITY INTEREST Recorded May 18, 2015
From: CREDIT SUISSE AG, AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 035706/0497 →
RELEASE OF SECURITY INTEREST Recorded May 18, 2015
From: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC; EMPI, INC.
Reel/Frame 035706/0457 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: MACQUARIE US TRADING LLC, AS COLLATERAL AGENT
Reel/Frame 035707/0398 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 035707/0454 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS THIRD LIEN AGENT
Reel/Frame 035707/0498 →
RELEASE OF SECURITY INTEREST Recorded Aug 27, 2014
From: BANK OF AMERICA, N.A.
To: REABLE THERAPEUTICS HOLDINGS LLC; REABLE THERAPEUTICS FINANCE LLC
Reel/Frame 033645/0576 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RICKO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 028078/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2008
From: COMPEX TECHNOLOGIES, INC.
To: ENCORE MEDICAL ASSET CORPORATION
Reel/Frame 021703/0351 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2008
From: REHABILICARE, INC.
To: COMPEX TECHNOLOGIES, INC.
Reel/Frame 021703/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2008
From: MOORE, GARY L.; CZECH, JOHN; WOLDEGIORGES, BISRAT; KARAS, MICHAEL
To: REHABILICARE, INC.
Reel/Frame 021673/0397 →
SECURITY AGREEMENT Recorded Dec 13, 2007
From: ENCORE MEDICAL ASSET CORPORATION
To: CREDIT SUISSE, AS COLLATERAL AGENT
Reel/Frame 020234/0433 →
SECURITY AGREEMENT Recorded Aug 31, 2007
From: REABLE THERAPEUTICS HOLDINGS LLC; REABLE THERAPEUTICS FINANCE LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 019767/0716 →